AJANTPHARM.NSE

Ajanta Pharma Ltd.

… Fincorp 11 Ajanta Pharma 12 Emcure Pharmaceuticals 13 Aadhar Housing … Kriti Nutrients 46 Jenburkt Pharma 47 Kriti Industries (India) … Coast Hotels 61 Sandu Pharmaceuticals 62 Premier Energy and … STL Networks 39 Shukra Pharmaceuticals 40 Alldigi Tech 41 …

Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, 2026. The company stated it will respond within the stipulated timeframe, while noting that Form-483 is issued when inspectors observe potential regulatory violations.

Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra from April 13–21, 2026. The company stated it will respond within the stipulated timeframe, while noting that Form-483 is issued when inspectors observe potential regulatory violations.

India's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.

India's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.

… in the highly successful weight-loss drugs called “Ozempic” and “Wegovy” developed … such as Mankind Pharma Ltd., Ajanta Pharma Ltd., Sun Pharmaceutical Industries Ltd. and … nearly 20% of all generic drugs available globally. The most significant impact …

… in the highly successful weight-loss drugs called “Ozempic” and “Wegovy” developed … such as Mankind Pharma Ltd., Ajanta Pharma Ltd., Sun Pharmaceutical Industries Ltd. and … nearly 20% of all generic drugs available globally. The most significant impact …

On March 13, Indian stock indices Sensex and Nifty 50 faced continued selling pressure due to rising crude oil prices and global economic concerns. GIFT Nifty today suggests a mildly positive start, with several stocks recommended for buying, including Ajanta Pharma and Power Grid Corporation.

On March 13, Indian stock indices Sensex and Nifty 50 faced continued selling pressure due to rising crude oil prices and global economic concerns. GIFT Nifty today suggests a mildly positive start, with several stocks recommended for buying, including Ajanta Pharma and Power Grid Corporation.